Future studies using knockout or transgenic PACSIN2 mice with experimentally induced DKD are needed to confirm whether changes in PACSIN2 levels affect podocyte survival and foot process effacement in vivo and understand the connection between PACSIN2, N-WASP and PKC. Here, PACSIN2 is linked to diabetic kidney disease.